PETS — PETMED EXPRESS INC
—
Nasdaq ·
Consumer Staples ·
Drug Retail ·
CIK 1040130 ·
Last close
$1.96
Market Cap
$41.89M
52W High
$2.45
52W Low
$1.62
ADV30
1,280,031
Next earnings
2026-08-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 42,817,000 | 13,942,000 | -5,692,000 | -4,061,000 | 81,191,000 | 21,412,000 | 52,251,000 |
| Dec 2025 | 40,660,000 | 9,456,000 | -10,469,000 | -10,553,000 | 87,965,000 | 26,914,000 | 55,199,000 |
| Sep 2025 | 44,364,000 | 12,415,000 | -8,380,000 | -8,520,000 | 100,301,000 | 36,098,000 | 57,237,000 |
| Jun 2025 | 51,180,000 | 14,403,000 | -6,874,000 | -34,152,000 | 109,839,000 | 41,127,000 | 58,293,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-28,394,000
Investing CF
$-4,615,000
Financing CF
$-299,000
CapEx
$-5,413,000
Dividends Paid
$-21,000
Buybacks
—
EPS Diluted TTM
$-2.59
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$9,263,000
Inventory
$13,608,000
Receivables
$1,908,000
ST Investments
—
EBIT TTM
$-31,415,000
Pretax Income TTM
$-57,359,000
Interest Exp TTM
—
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$179,020,992
EBITDA
$-19,000,000
Free Cash Flow
$-20,371,876
Enterprise Value
$20,344,288
Total Cash
$21,412,000
Total Debt
$535,000
Shares Out
21,371,880
Trailing EPS
$-2.74
Book Value
$1.53
ROE
-100.4%
ROA
-15.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 179,021,000 | -31,415,000 | -57,286,000 | 81,191,000 | 52,251,000 | — | -28,394,000 |
| Mar 2025 | — | — | — | — | — | — | — |
| Mar 2024 | 274,095,000 | -8,162,000 | -7,464,000 | 169,884,000 | 73,153,000 | — | 4,317,000 |
| Mar 2023 | 247,569,000 | 6,051,000 | 5,140,000 | 167,478,000 | 57,512,000 | — | 27,803,000 |
| Mar 2022 | 272,282,000 | 24,290,000 | 18,716,000 | 179,698,000 | 56,248,000 | — | 18,498,000 |
TTM Snapshot
Revenues TTM
$241,542,000
NetIncome TTM
$-367,000
OpCashFlow TTM
$0
Assets (Latest)
$148,700,000
Forward EPS
$-0.03
Max Pain — expiry 2026-09-18
max pain strike: $2.50 · spot: $1.96 · call oi: 3,637 · put oi: 0
Expected Move to 2026-09-18:
±$0.93
(47.19%) —
implied range
$1.04 –
$2.89
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| YI | 111, Inc. | $21.83M | $4.20 | — |
| AIXN | AiXin Life International, Inc. | $6.50M | $0.26 | — |
| CANN | TREES Corp (Colorado) | $2.76M | $0.02 | — |
| RDGT | Ridgetech Inc. | $1.36M | $1.51 | — |
| GRDN | Guardian Pharmacy Services, Inc. | $2.04B | $40.96 | — |
News headlines (Yahoo Finance, 1h cache)
PetMed Express, Inc. Confirms Receipt of Unsolicited, Non-Binding, and Conditional Acquisition Proposal from SilverCape Investments Limited
2026-06-30 13:15 · Yahoo
SilverCape Releases Revised Proposal to Acquire PetMed Express for $3.00 per Share in Cash
2026-06-29 11:08 · Yahoo
What makes PetMed Express, Inc. (PETS) one of the Best Pet Care Stocks to Buy for Consistent Recurring Revenue?
2026-06-22 13:31 · Yahoo
PETS Q4 Earnings Call Focuses on Turnaround Foundation
2026-06-05 09:11 · Yahoo
PetMed Express Inc (PETS) Q4 2026 Earnings Call Highlights: Navigating Challenges and Embracing ...
2026-06-03 05:00 · Yahoo
PetMed Express (PETS) Q4 2026 Earnings Transcript
2026-06-03 00:52 · Yahoo
PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results
2026-06-02 20:05 · Yahoo
PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026
2026-05-29 12:00 · Yahoo
PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels
2026-04-22 20:05 · Yahoo
Promising Penny Stocks To Consider In February 2026
2026-02-17 12:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.